We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+24.53%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$7.44B
AUM Growth
+$2.18B
Cap. Flow
+$1.12B
Cap. Flow %
15.11%
Top 10 Hldgs %
13.07%
Holding
2,045
New
726
Increased
371
Reduced
415
Closed
520

Sector Composition

Rank Sector Weight
1 Financials 19.3%
2 Technology 16.73%
3 Consumer Discretionary 13.16%
4 Industrials 8.74%
5 Healthcare 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCJ icon
676
Cameco
CCJ
$40.8B
$1.54M 0.02%
+114,800
New +$1.23M
ARCT icon
677
Arcturus Therapeutics
ARCT
$173M
$1.53M 0.02%
35,268
-129,102
-79% -$8.74M
WEC icon
678
WEC Energy
WEC
$35.2B
$1.53M 0.02%
16,567
-55,753
-77% -$5.42M
DAR icon
679
Darling Ingredients
DAR
$9.62B
$1.52M 0.02%
26,425
-17,248
-39% -$824K
ATEX icon
680
Anterix
ATEX
$1.96B
$1.52M 0.02%
40,466
-130,000
-76% -$4.28M
MFC icon
681
Manulife Financial
MFC
$74B
$1.52M 0.02%
+86,100
New +$1.37M
PAYA
682
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
$1.51M 0.02%
+111,100
New +$1.29M
CLR
683
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$1.51M 0.02%
92,500
+63,957
+224% +$956K
ANF icon
684
Abercrombie & Fitch
ANF
$4.91B
$1.49M 0.02%
+73,300
New +$1.34M
ENDP
685
DELISTED
Endo International plc
ENDP
$1.48M 0.02%
+206,750
New +$1.08M
GOCO
686
DELISTED
GoHealth
GOCO
$1.48M 0.02%
7,227
+3,467
+92% +$644K
CELL
687
DELISTED
PhenomeX Inc. Common Stock
CELL
$1.47M 0.02%
+16,450
New +$1.38M
ICAD
688
DELISTED
iCAD Inc
ICAD
$1.46M 0.02%
110,700
-227,300
-67% -$2.45M
FOLD
689
DELISTED
Amicus Therapeutics
FOLD
$1.46M 0.02%
63,072
-100,619
-61% -$2.06M
PFE icon
690
Pfizer
PFE
$149B
$1.45M 0.02%
+39,500
New +$1.45M
PBCT
691
DELISTED
People's United Financial Inc
PBCT
$1.45M 0.02%
+112,467
New +$1.35M
JLL icon
692
Jones Lang LaSalle
JLL
$16.7B
$1.44M 0.02%
9,693
-3,592
-27% -$461K
KMB icon
693
Kimberly-Clark
KMB
$36.1B
$1.44M 0.02%
10,645
-5,258
-33% -$736K
VMW
694
DELISTED
VMware, Inc
VMW
$1.43M 0.02%
10,200
+8,468
+489% +$1.21M
SNRHU
695
DELISTED
Senior Connect Acquisition Corp. I Unit
SNRHU
$1.43M 0.02%
+138,900
New +$1.43M
AEL
696
DELISTED
American Equity Investment Life Holding Company
AEL
$1.43M 0.02%
+51,549
New +$1.42M
SIBN icon
697
SI-BONE Inc
SIBN
$813M
$1.42M 0.02%
47,600
+26,224
+123% +$639K
TFII icon
698
TFI International
TFII
$11.3B
$1.41M 0.02%
+27,400
New +$1.36M
IDXX icon
699
Idexx Laboratories
IDXX
$46.5B
$1.4M 0.02%
+2,800
New +$1.25M
TKR icon
700
Timken Company
TKR
$8.92B
$1.39M 0.02%
18,000
+10,500
+140% +$715K

Similar funds

Schonfeld Strategic Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Schonfeld Strategic Advisors held 2,045 positions worth $7.44B, up 42% from $5.25B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Schonfeld Strategic Advisors deployed $1.12B of net new capital in Q4 2020, opening 726 new positions and adding to 371 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 272,911 shares worth $102M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Crown Holdings, an estimated $43.8M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 272,911 shares worth $102M.
  • Schonfeld Strategic Advisors added most to US Bancorp in Q4 2020, an estimated $62.4M increase.
  • Schonfeld Strategic Advisors's biggest Q4 2020 reduction was Crown Holdings, cutting an estimated $43.8M.
  • Schonfeld Strategic Advisors fully exited Claritev Corp in Q4 2020, selling an estimated $30.8M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 13% of its $7.44B portfolio in Q4 2020.
  • Schonfeld Strategic Advisors opened 726 new positions and closed 520 in Q4 2020.
  • Schonfeld Strategic Advisors's portfolio value rose 42% quarter-over-quarter to $7.44B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.